We are live on ! Find out more
RKDA icon

Arcadia Biosciences
RKDA

12 hedge funds and large institutions have $1.22M invested in Arcadia Biosciences in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

0.02% less ownership

Funds ownership: 0.14% → 0.12% (-0.02%)

14% less funds holding

Funds holding: 14 → 12 (-2)

55% less capital invested

Capital invested by funds: $2.72M → $1.22M (-$1.5M)

Holders
12
Holders Change
-2
Holders Change %
-14.29%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$192K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$105K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$64.9K
4
Wells Fargo
Wells Fargo
California
+$51.5K
5
Citadel Advisors
Citadel Advisors
Florida
+$49.8K

Top Sellers

Rank Fund Capital Flow
1
AAP
Ardsley Advisory Partners
Connecticut
-$548K
2
OAM
Oxford Asset Management
United Kingdom
-$191K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$164K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$74K
5
UBS Group
UBS Group
Switzerland
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$731K +$105K +606 +10%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$139K +$47.3K +272 +28%
Renaissance Technologies
3
Renaissance Technologies
New York
$126K +$192K +1,102 New
Northern Trust
4
Northern Trust
Illinois
$54K – – –
Wells Fargo
5
Wells Fargo
California
$46K +$51.5K +296 +262%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$42K +$64.9K +373 New
Morgan Stanley
7
Morgan Stanley
New York
$40K +$13.2K +76 +28%
Citadel Advisors
8
Citadel Advisors
Florida
$33K +$49.8K +286 New
Victory Capital Management
9
Victory Capital Management
Texas
$6K +$10.6K +61 New
CA
10
Clearstead Advisors
Ohio
$3K +$4.35K +25 New
BlackRock
11
BlackRock
New York
$1K – – –
AAP
12
Ardsley Advisory Partners
Connecticut
– -$548K -2,503 Closed
OAM
13
Oxford Asset Management
United Kingdom
– -$191K -874 Closed
Bank of Montreal
14
Bank of Montreal
Ontario, Canada
– -$164K -751 Closed
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
– -$74K -337 Closed
UBS Group
16
UBS Group
Switzerland
– -$12K -56 Closed
EE
17
EWG Elevate
California
– -$3K -13 Closed
TRCT
18
Tower Research Capital (TRC)
New York
– +$348 +2 New

RKDA Hedge Fund Activity: Q1 2020 in Review

12 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q1 2020, worth a combined $1.22M — down 55% from $2.72M a quarter earlier.

Fund positioning in RKDA was balanced in Q1 2020: 6 funds opened new positions, 6 closed out, 4 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $192K. The largest seller was Ardsley Advisory Partners, exiting entirely with an estimated $548K sold.

  • 12 institutional investors held Arcadia Biosciences (RKDA) as of Q1 2020, down from 14 in Q4 2019.
  • Funds reported $1.22M of Arcadia Biosciences stock for Q1 2020, down 55% quarter-over-quarter.
  • 6 funds opened new Arcadia Biosciences positions in Q1 2020 and 6 closed out, a net change of 0 holders.
  • The largest Arcadia Biosciences buyer in Q1 2020 was Renaissance Technologies, an estimated $192K added.
  • The largest Arcadia Biosciences seller in Q1 2020 was Ardsley Advisory Partners, an estimated $548K sold.

Based on aggregated 13F filings for Q1 2020.